Loading clinical trials...
Loading clinical trials...
Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of ATX-101 (Sodium Deoxycholate Injection) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area
Conditions
Interventions
Deoxycholic acid injection
Placebo
Locations
30
Belgium
Investigational Site
Oudenaarde, Minderbroederstaraat, Belgium
Investigational Site
Arras, France
Investigational Site
Cannes, France
Investigational Site
Nice, France
Investigational Site
Pantin, France
Investigational Site
Paris, France
Start Date
December 1, 2010
Primary Completion Date
January 1, 2012
Completion Date
January 1, 2012
Last Updated
July 14, 2015
Lead Sponsor
Kythera Biopharmaceuticals
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions